Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia Areata has no guaranteed treatment for hair regrowth, but options like corticosteroids and minoxidil are used, with future research focusing on genetic and immune therapies.

Current and future treatments for alopecia areata focus on immunosuppression, immunomodulation, and protecting hair follicles.

The conclusion suggests a possible link between iron levels and hair health in women, recommending further research on iron supplementation for hair loss.

People with alopecia areata often have lower vitamin D levels, which are linked to more severe and longer-lasting hair loss, but vitamin D receptor levels in the skin don't show the same pattern and don't predict treatment success.

Topical anthralin helped regrow hair in mice with a condition similar to human alopecia.

Female donor to male recipient sex mismatch and positive ACA-IgG are key risk factors for vitiligo and alopecia areata in chronic GvHD patients.

Diphencyprone treatment increases CD8 lymphocytes in the scalp, which is associated with hair regrowth in alopecia areata patients.

The cause of alopecia areata is likely a mix of genetics, immune system issues, and environmental factors, with more research needed to understand it fully.

Alopecia areata causes hair loss due to an immune attack on hair follicles, influenced by genetics and environment.

Higher interleukin-15 levels are linked to more severe alopecia areata, but not to age or gender.

The laser comb did not improve hair regrowth in mice with alopecia areata.

A woman's hair loss worsened after starting hepatitis C treatment due to immune changes in her hair follicles.

New targeted therapies for hair loss from alopecia areata show promise, with personalized treatment expected in the future.

Alopecia areata patients have lower zinc, copper, and selenium levels than healthy people.

The girl's regrown brown hair had less of certain pigments than her original black hair.

A newborn with congenital syphilis had unusual hair loss possibly caused by the infection.

Alopecia areata in US adolescents leads to significant healthcare costs and usage.

A girl with Crohn's disease developed hair loss from her medication, which improved with treatment but later returned.

Immunization and throat bacteria may increase the risk of a hair loss condition called alopecia areata.

Alopecia Areata is an autoimmune disease causing hair loss, with no cure yet, but research may lead to new treatments.

A woman with alopecia regrew her hair after taking a higher dose of tocilizumab.

People with alopecia areata often have lower vitamin D levels than healthy people.

A woman's hair grew back after stopping acitretin for psoriasis and getting steroid treatment, and low vitamin D might be linked to alopecia severity.

The document concludes that alopecia areata is an unpredictable autoimmune hair loss condition with no cure, but various treatments exist that require personalized approaches.

The document says a skin condition called alopecia areata causes hair loss and stress, and is treated with strong skin creams, injections, or other therapies, but treatment success varies.

Platelet-rich plasma treatment is not very effective for chronic severe alopecia areata.

Alopecia areata causes patchy hair loss due to unknown factors, affecting all ages and genders.

STS01 1% effectively promotes hair regrowth with minimal side effects.

Children with alopecia areata often have vitiligo, allergic asthma, ADHD, and low vitamin B12 and ferritin levels.

Oral tofacitinib effectively treats alopecia areata long-term with manageable side effects.